Home Investors News Press Releases

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.

Select a month	AllJanuary February March April May June July August September October November December
Select a year	All2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Search for:

07/14/2008	Cyclacel publishes study of seliciclib synergy with Tarceva and Herceptin in journal Clinical Cancer Research
07/07/2008	XCLAIR® reported to be safe and effective in study published in European Journal of Dermatology
07/02/2008	Cyclacel to present at Collins Stewart Fourth Annual Growth Conference
06/06/2008	Cyclacel to present at Annual Needham Biotechnology & Medical Technology Conference
05/29/2008	Vall d’Hebron University Hospital and Cyclacel to initiate Phase 1 combination study of Seliciclib and Tarceva®
05/27/2008	Cyclacel’s Sapacitabine receives orphan designation for AML & MDS from EU regulators
05/15/2008	May 2008 Investment Banking Conferences
05/09/2008	Cyclacel Pharmaceuticals announces first quarter 2008 financial results
04/28/2008	Cyclacel Pharmaceuticals announces May 2008 corporate events
04/16/2008	Cyclacel Pharmaceuticals presents insights into the mechanisms of its cell cycle inhibitor drugs
1  2    >>

  Go to top      Print page